logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers 9
  • 1
    Harte, Brendan
    Born in May 1965
    Individual (11 offsprings)
    Officer
    2020-01-22 ~ 2023-10-12
    OF - Director → CIF 0
  • 2
    Fox, Erina
    Individual (26 offsprings)
    Officer
    2020-01-22 ~ now
    OF - Secretary → CIF 0
  • 3
    Grove, Harvey Gordon Edwin
    Born in May 1948
    Individual (7 offsprings)
    Officer
    2012-12-11 ~ 2021-04-08
    OF - Director → CIF 0
  • 4
    Sorrel, Sarah Anne
    Born in September 1957
    Individual (3 offsprings)
    Officer
    2012-12-11 ~ 2021-04-08
    OF - Director → CIF 0
  • 5
    Hollywood, Simon
    Born in January 1980
    Individual (6 offsprings)
    Officer
    2023-10-12 ~ now
    OF - Director → CIF 0
  • 6
    O'boyle, Bryan
    Born in October 1982
    Individual (3 offsprings)
    Officer
    2020-01-22 ~ 2023-10-12
    OF - Director → CIF 0
  • 7
    Lyons, Emer
    Born in January 1978
    Individual (10 offsprings)
    Officer
    2023-10-12 ~ now
    OF - Director → CIF 0
  • 8
    Gleeson, Michael
    Born in November 1978
    Individual (21 offsprings)
    Officer
    2020-01-22 ~ 2022-10-21
    OF - Director → CIF 0
  • 9
    ICON CLINICAL RESEARCH (U.K.) NO. 6 LIMITED
    - now 09743789 08326602... (more)
    MEDPASS GROUP LIMITED - 2021-04-19 09743789
    500, South Oak Way, Green Park, Reading, United Kingdom
    Active Corporate (9 parents, 2 offsprings)
    Person with significant control
    2016-04-06 ~ now
    PE - Ownership of shares – 75% or moreCIF 0
    PE - Ownership of voting rights - 75% or moreCIF 0
parent relation
Company in focus

ICON CLINICAL RESEARCH (U.K.) NO. 5 LIMITED

Period: 2021-04-19 ~ now
Company number: 08326602 09743789... (more)
Registered names
ICON CLINICAL RESEARCH (U.K.) NO. 5 LIMITED - now 09743789... (more)
MEDPASS LIMITED - 2021-04-19
Standard Industrial Classification
70100 - Activities Of Head Offices
Brief company account
Administrative Expenses
-4,221 GBP2024-01-01 ~ 2024-12-31
1,820 GBP2023-01-01 ~ 2023-12-31
Distribution Costs
8,110 GBP2024-01-01 ~ 2024-12-31
253,055 GBP2023-01-01 ~ 2023-12-31
Profit/Loss on Ordinary Activities Before Tax
3,889 GBP2024-01-01 ~ 2024-12-31
254,875 GBP2023-01-01 ~ 2023-12-31
Profit/Loss
3,889 GBP2024-01-01 ~ 2024-12-31
257,384 GBP2023-01-01 ~ 2023-12-31
Debtors
1,407,355 GBP2024-12-31
1,397,243 GBP2023-12-31
Cash at bank and in hand
91,828 GBP2024-12-31
95,891 GBP2023-12-31
Current Assets
1,499,183 GBP2024-12-31
1,493,134 GBP2023-12-31
Creditors
Current, Amounts falling due within one year
-2,160 GBP2024-12-31
Net Assets/Liabilities
1,497,023 GBP2024-12-31
1,493,134 GBP2023-12-31
Equity
Called up share capital
100 GBP2024-12-31
100 GBP2023-12-31
100 GBP2022-12-31
Retained earnings (accumulated losses)
1,496,923 GBP2024-12-31
1,493,034 GBP2023-12-31
1,235,650 GBP2022-12-31
Equity
1,497,023 GBP2024-12-31
1,493,134 GBP2023-12-31
1,235,750 GBP2022-12-31
Profit/Loss
Retained earnings (accumulated losses)
3,889 GBP2024-01-01 ~ 2024-12-31
257,384 GBP2023-01-01 ~ 2023-12-31
Average number of employees in administration and support functions
12024-01-01 ~ 2024-12-31
12023-01-01 ~ 2023-12-31
Average Number of Employees
32024-01-01 ~ 2024-12-31
32023-01-01 ~ 2023-12-31
Audit Fees/Expenses
1,000 GBP2024-01-01 ~ 2024-12-31
2,100 GBP2023-01-01 ~ 2023-12-31
Tax Expense/Credit at Applicable Tax Rate
969 GBP2024-01-01 ~ 2024-12-31
59,948 GBP2023-01-01 ~ 2023-12-31
Amounts Owed By Related Parties
1,405,355 GBP2024-12-31
1,397,243 GBP2023-12-31
Other Debtors
2,000 GBP2024-12-31
Other Creditors
2,160 GBP2024-12-31
Par Value of Share
Class 2 ordinary share
12024-01-01 ~ 2024-12-31
Number of Shares Issued (Fully Paid)
Class 2 ordinary share
70 shares2024-12-31
70 shares2023-12-31
Par Value of Share
Class 3 ordinary share
12024-01-01 ~ 2024-12-31
Number of Shares Issued (Fully Paid)
Class 3 ordinary share
10 shares2024-12-31
10 shares2023-12-31
Par Value of Share
Class 4 ordinary share
12024-01-01 ~ 2024-12-31
Number of Shares Issued (Fully Paid)
Class 4 ordinary share
10 shares2024-12-31
10 shares2023-12-31
Number of Shares Issued (Fully Paid)
100 shares2024-12-31
100 shares2023-12-31

  • ICON CLINICAL RESEARCH (U.K.) NO. 5 LIMITED
    Info
    MEDPASS LIMITED - 2021-04-19
    MEDPASS INTERNATIONAL HOLDINGS LIMITED - 2021-04-19
    Registered number 08326602
    3rd Floor, North & South Wings 100 Longwater Avenue, Green Park, Reading, Berkshire RG2 6GP
    PRIVATE LIMITED COMPANY incorporated on 2012-12-11 (13 years 5 months). The status of the company number is Active.
    The last date of confirmation statement was made at 2026-03-15
    CIF 0
child relation
Offspring entities and appointments 0
  • Not found in our database.

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 22 April 2026 and licensed under the Open Government Licence v3.0.